Virtual Clinical Trials

VCT with your surgical technique and our large patient data base.

The OptimeyesTM simulation framework can do much more than the CE marked product. Although not directly applicable to patients, the software can be used to run parametric simulation studies on our large cases database. Clinical Directors can save time and money with “virtual clinicals”. The virtual clinical trials are executed based on data cases stored in our Optimeyes data base. 

Virtual Clinical Studies


Profit from the unique combination of expertise in corneal biomechanics, ANSYS’ robust numerical simulation platform, and the Optimeyes tools. With years of experience in research in the field of corneal biomechanics and simulation, we provide you with consulting and expertise for your questions. With our software suite we can offer support in answering your development questions, and in understanding corneal behavior.

Some examples of studies which were run with OptimeyesTM are given in the following list:

  • Parameter sensitivity analysis (optical zone, incision depth, off-axis, ...) in Arcuate Keratotomy.
  • Comparison of biomechanical effects and stability after LASIK vs SMILE surgery.
  • Contact lens placement on the cornea.
  • Impact of patient-interface shape on femto-second laser incisions.
  • Refractive effect of patterned collagen cross-linking.
  • Effect of corneal inlay implantation depth on biomechanics and corneal topography.
  • ...


Avicenna Alliance

Optimo Medical is very happy to be part of the Avicenna Alliance since 2018. 

Avicenna Alliance is an association originating from a EU funded project which serves as a representative for in silico medicine toward the EU. In silico medicine is on the rise and our software is well-suited for it. To learn more about the potential of virtual clinical trials with OptimeyesTM, visit the respective page in the industry section of our webpage. If you are interested to learn more about the Avicenna Alliance, head on over to their page, where they also annnounce us as a new member.

In this Video, Avicenna Alliance members discuss the possibilities which in silico medicine can bring in the futuer (skip to minute 03:00 to hear the arguments from Optimo Medical's CEO, Harald Studer):